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Zheng-hua Xiao†, Jia Hu†, Da Zhu, Ying-kang Shi and Er-yong Zhang*Abstract
Myxomas are the most common primary cardiac tumors. The cardiac myxomas are mostly diagnosed within the
atria, and only a few such tumors are reported to have arisen from atrioventricular valves or pulmonary vessels. The
authors here present a case of 59-year-old Chinese woman who was hospitalized for exacerbating symptoms of
tricuspid stenosis and right heart failure. Echocardiography revealed a giant right atrial myxoma arising from an
extremely rare site, the anterior wall of the superior vena cava. With the aid of transesophageal echocardiography,
the surgical resection was performed successfully with the patient achieving complete recovery.
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Primary cardiac tumor represents a rare subgroup of
malignancies in humans with an incidence between 0.0017
and 0.29 percent in autopsy series performed in non-
selected populations [1,2]. The most prevalent type of the
intra-cardiac tumor is myxoma, which is approximately
0.5-1 cases per 106 individuals per year, with apparent pre-
ponderance (3:1) of female patients [3,4]. Although the
majority of cardiac myxomas (CMs) are histologically be-
nign, due to their strategic location (left or right cardiac
chamber) and nature (size, mobility and overall morph-
ology), they may lead to serious consequences for morbid-
ity and mortality of affected patients.
The occurrence of CMs is mainly sporadic (90%) and
is commonly observed within the left atrium (60-80%)
[1,2,5]. As reported by previous studies, about 15-28% of
CMs are diagnosed in the right atrium, 8% in the right
and 3-4% in the left ventricle, and a small proportion of
CMs are biatrial [1,2,6,7]. There are also less common
reports of CMs involving all cardiac chambers and origin-
ating from mitral leaflets, aortic valves and pulmonary
vessels [7-11]. Here we present an extremely rare case of a* Correspondence: zey16@126.com
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reproduction in any medium, provided the orgiant superior vena cava (SVC)-originated myxoma mim-
icking tricuspid valve obstruction and right heart failure.Case presentation
A 59-year-old Chinese woman with a 10-year history of
exertional dyspnea and palpitations was hospitalized for
exacerbating symptoms of right heart failure from one
month prior to admission. On physical examination, her
pulse rate was 99 beats per minute, and blood pressure
was 111/80 mmHg. She had moderate bilateral pitting
leg edema, a distended jugular vein and mild dilatation
of superficial neck and facial veins. An accentuated sec-
ond heart sound without tumor plop was heard on aus-
cultation. Electrocardiogram showed sinus rhythm with
right bundle branch block. Chest X-ray and abdominal
computed tomography were unremarkable. The results
of lower extremity ultrasound were negative for deep
venous thrombosis. A transesophageal echocardiogram
(TEE) demonstrated a mobile and pedunculated giant
mass (68 mm× 49 mm) in the enlarged right atrium
(70 mm× 53 mm) arising from the anterior wall of the
SVC (Figure 1). The mass prolapsed into the right ventricle
across the tricuspid valve during systole (Additional file 1:
Video 1), resulting in tricuspid orifice obstruction and
symptoms of right heart failure (Figure 2).
The patient underwent surgical intervention through a
median sternotomy and on normothermic cardiac arrestd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Transesophageal echocardiography demonstrated a giant mass arising from the SVC. A) Transesophageal echocardiography
revealed a giant mass arising from the anterior wall of the superior vena cava (SVC); B) The cavity of the SVC was occupied by the mass.
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fragmentation, care was particularly taken during venous
cannulation after pericardiotomy. Briefly, an ultrasound
probe was placed transversely on the patient’s right neck,
and the short-axis of right internal jugular vein was
clearly visualized. A venous cannula (15 Fr) was then
inserted into the right internal jugular vein using the
Seldinger technique. With the guidance of TEE, the tip
of cannula was properly positioned in the distal segment
of SVC. Similarly, TEE was performed to assess the loca-
tion of the myxoma prior to the cannulation of inferiorFigure 2 Transesophageal echocardiography demonstrated an
enlarged cavity of the right atrium with the mass prolapsing
through the tricuspid orifice into the right ventricle during
diastole. RA, right atrium; RV, right ventricle; LA, left atrium; LV,
left ventricle.vena cava, keeping the cannulation site as far as possible
to prevent a potential mass fragmentation. After opening
the right atrium, a grey-green translucent mass in the
atrial chamber with a pedicle attached to the anterior
wall of the SVC was identified and was then completely
excised, no endocardial adhesions in right atrium or
ventricle was observed. A glutaraldehyde preserved au-
tologous pericardium was used for patch reconstruction
of the anterior wall of the SVC. The tricuspid valve ap-
peared structurally normal, and tricuspid regurgitation
was trivial. Histopathologic examination demonstrated a
hypocellular benign tumor containing satellite polygonal
cells with scant eosinophilic cytoplasm scattered through-
out an acid-mucopolysaccharide-rich stroma (Figure 3).
Postoperatively, transthoracic echocardiography (TTE)
showed normal biventricular function without any re-
sidual myxoma and significant tricuspid regurgitation,
and the patient had an uneventful recovery and was dis-
charged home at 7 days after surgery.
Discussion
Myxomas are the most common primary cardiac tumors
in adults, constituting up to 50-85% of all benign lesions
[1,2,8,12]. As reported by literatures, CMs are more
common in women and occur much more frequently
between the third and sixth decades of life [1-4]. It is be-
lieved that embryonic residues after the in-utero sept-
ation of the heart are those that give rise to the myxoma
[13]. Thus, CMs may originate from anywhere within
the cardiac chambers. Actually, majority of CMs occur
in the atria with only 3-10% identified in either the left
or right ventricle. The left atrium is the most common
site with greater than 75% of all myxomas arising from
here, and the right-sided location accounts for only 20%
of cases [1,8]. Only a few such tumors are reported to
have arisen from atrio-ventricular valves, pulmonary
Figure 3 High power field (×200 fold) of a representative section of the myxoma demonstrating a hypocellular benign tumor
containing satellite polygonal cells with scant eosinophilic cytoplasm scattered throughout an acid-mucopolysaccharide-rich stroma.
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there are several literatures reporting CMs-related in-
volvement of SVC, these intra-cardiac neoplasms are ex-
clusively originated from right atrium [16,17]. The
present case is of interest because of the rarity of the
tumor itself, which had a pedicle from an extremely rare
site SVC, occupied almost the entire right atrial cavity,
prolapsed into the right ventricle across the tricuspid
valve during systole, and caused symptoms resembling
tricuspid stenosis and right heart failure. This rare origin
has only been reported previously by Teixido et al. [18],
however, no signs of tricuspid obstruction and right
heart failure were observed.
Besides nonspecific constitutional symptoms such as fe-
vers, arthralgia and erythematous rash, patients with CMs
generally present with hemodynamic derangement due to
intra-cardiac obstruction and signs of systemic or pulmon-
ary embolization caused by mass fragmentation [1,5,8].
Atrioventricular valve obstruction with corresponding-
sided heart failure, as demonstrated in our case, is the
major cause of acute presenting symptoms of CMs that fa-
cilitate their initial diagnosis. As patients with CMs may
demonstrate a wide spectrum of cardiac and non-cardiac
symptoms, early and accurate diagnosis is ultimately im-
portant in the clinical management of these patients. The
echocardiography, both the transthoracic and transesoph-
ageal approach, is able to determine the location, size,
shape, mobility and attachment of CMs. In the present
case, TEE not only characterizes the tumor more clearly
than TTE, it also plays a pivotal role in determining can-
nulation strategy during surgical treatment.Currently, the treatment of choice for effective therapy
of CMs is surgical resection, which is curative. Cardiac
surgery should be performed as soon as possible in order
to prevent major adverse complications associated with
the tumor. As reported by others, the perioperative mor-
tality is low and the long-term prognosis is satisfactory
[19,20]. In the present case, due to the size of the mass,
we preferred to excise the myxoma during cardiac arrest
with the aid of cardiopulmonary bypass. However, it is
challenging for us to cannulate the SVC because of the
particular location of the mass. Under the guidance of
TEE, we managed to drain the SVC blood through the
cannulation of the right internal jugular vein and then
excise the myxoma completely. Another concern in the
surgical treatment of the CMs is the postoperative recur-
rence. Recurrence after surgical resection of primary le-
sions has been observed in 1-4% of sporadic and 12-22%
of familial cases [1,2,7]. The possible explanations for
the CMs recurrence are familial predisposition, unre-
cognized multifocal origin of primary lesion, incomplete
resection or intraoperative dissemination of tumor cells
[2,8,12,19]. Therefore, considering the rare origin of this
myxoma and the experience learned from Teixido’s re-
port [18], we decided to excise the myxoma and its at-
tachment site (a part of the anterior wall of the SVC)
completely, trying to minimize the risk of intra-cardiac
recurrence.
Conclusions
Symptomatic tricuspid obstruction and right heart fail-
ure due to intra-cardiac myxoma originating from SVC
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the surgical removal could be performed successfully and
the risk of postoperative recurrence might be minimized.
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